LKT Labs, 1271022-90-2, Chemicals
1 - 1 of 1
Sort
View
Show
-
BMS-911543
LKT LabsBMS-911543 is an oral selective inhibitor of JAK2 currently in clinical trials. BMS-911543 shows anticancer activity through inhibition of the JAK/STAT signaling cascade in in vitro and in vivo models of myeloproliferative neoplasms, which display constitutively active JAK2 signaling. This compound…
Site Search by